SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has announced the exercise of 10,000 Share Options under their Post-IPO Option Plan, leading to the issue of an equivalent number of new shares. This has brought the total number of issued shares to 630,335,112. Additionally, there are now 66,438,952 Share Options remaining, with various terms and vesting statuses detailed by the company.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.